Skip to Content

Vazculep Approval History

  • FDA approved: Yes (First approved June 27th, 2014)
  • Brand name: Vazculep
  • Generic name: phenylephrine hydrochloride
  • Dosage form: Injection
  • Company: Flamel Technologies
  • Treatment for: Hypotension

Vazculep (phenylephrine hydrochloride) injection is an alpha-1 adrenergic receptor agonist indicated for the treatment of hypotension resulting primarily from vasodilation in the setting of anesthesia.

Development History and FDA Approval Process for Vazculep

Jun 30, 2014Approval Flamel Technologies Announces FDA Approval of Vazculep

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.